Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration.

Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, Zhang B, Yue Z. · 2020

Read Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration. by Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, Zhang B, Yue Z. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7069981.txt.

Introduction

Choi and co-authors uncover a brain cleanup service in Nature Communications. Microglia keep the brain tidy by removing debris. The protein alpha-synuclein, released by neurons, is a suspect in Parkinson's and related diseases when it misfolds and piles up. Whether microglia can clear the released protein, and how, was the open question behind this study.

Neuron-released alpha-synuclein switches microglia on. The microglia swallow the protein into autophagosomes, self-digesting pouches, and destroy it through a selective form of autophagy the authors name synucleinphagy. The process needs the microglial receptor TLR4, which drives output of p62, a tag that gathers the protein into clusters marked for disposal. In mice expressing human alpha-synuclein, breaking microglial autophagy let misfolded protein build up and killed midbrain dopamine neurons, the very cells lost in Parkinson's disease. The pathway offers a protective mechanism that future therapies might strengthen.

Catalog record

CREATORChoi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, Zhang B, Yue Z.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE82 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7069981

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration By Insup Choi, Yuanxi Zhang, Steven P Seegobin, Mathilde Pruvost, Qian Wang, Kerry Purtell, Bin Zhang, Zhenyu Yue Published in: Nature Communications DOI: 10.1038/s41467-020-15119-w ABSTRACT Abstract Microglia maintain brain homeostasis by removing neuron-derived components such as myelin and cell debris. The evidence linking microglia to neurodegenerative diseases is growing; however, the precise mechanisms remain poorly understood. Herein, we report a neuroprotective role for microglia in the clearance of neuron-released α-synuclein. Neuronal α-synuclein activates microglia, which in turn engulf α-synuclein into autophagosomes for degradation via selective autophagy (termed synucleinphagy). Synucleinphagy requires the presence of microglial Toll-like receptor 4 (TLR4), which induces transcriptional upregulation of p62/SQSTM1 through the NF-κB signaling pathway. Induction of p62, an autophagy receptor, is necessary for the formation of α-synuclein/ubiquitin-positive puncta that are degraded by autophagy. Finally, disruption of microglial autophagy in mice expressing human α-synuclein promotes the accumulation of misfolded α-synuclein and causes midbrain dopaminergic neuron degeneration. Our study thus identifies a neuroprotective function of microglia in the clearance of α-synuclein via TLR4-NF-κB-p62 mediated synucleinphagy. Subject terms: Macroautophagy, Microglia INTRODUCTION α-synuclein is produced primarily in neurons and constitutes up to 1% of total cytosolic protein in the brain1. Although the function of α-synuclein is poorly understood, available evidence suggests its role in synaptic vesicular trafficking2–4. Aggregated α-synuclein is a major component in intraneuronal inclusions known as Lewy bodies (LB) associated with neurodegenerative diseases, such as Parkinson’s disease (PD) and dementia with Lewy body (DLB)5,6. Increased α-synuclein level due to the multiplication of SNCA alleles is causal to PD7,8. Previous evidence suggested “prion-like” cell-to-cell transmission of α-synuclein9,10. α-synuclein can be secreted by neurons as a result of cellular stress or injury, or as a response to stimulation11–13. Neighboring neurons and glia can engulf and clear extracellular α-synuclein and thus contributing to the regulation of α-synuclein homeostasis in the brain. Interestingly, injection of fibrillar α-synuclein into animal brains causes the spread of LB-like pathology14, supporting the “Braak hypothesis” of staging in synucleinopathies15. Therefore, cellular uptake and clearance pathways are key processes to control the deposition and spread of α-synuclein aggregates, thus affecting disease progression. Although neurons and glia in the brain can ingest and degrade extracellular α-synuclein, microglia show the highest efficiency in vitro16. Extensive effort has been made toward the identification of cellular pathways of α-synuclein clearance. Several studies reported receptor-mediated internalization of various forms of α-synuclein in neurons and glial cells17–19. However, the exact mechanism for the clearance of internalized α-synuclein remains unclear. Previous studies suggest that α-synuclein is degraded by macroautophagy, chaperone-mediated autophagy, and the proteasome20–23. However, the evidence for macroautophagy (hereafter referred to as autophagy) degradation of α-synuclein is extremely limited24,25. Autophagy is a bulk degradation pathway responsible for the clearance of protein aggregates and damaged cellular organelles26,27. Recent evidence demonstrates a strong selectivity for autophagy28. Direct evidence for autophagy in selective degradation of α-synuclein is entirely lacking. Furthermore, since most of the studies of α-synuclein degradation were focused on neurons, whether or not microglia, the prototypical scavenger cell in the brain, take part in the degradation of α-synuclein remains unclear. Here, we report that microglia ingest and degrade neuron-released α-synuclein through selective autophagy in vitro and in vivo. We document that ingested α-synuclein in microglia is sequestered by autophagosomes for degradation, which is mediated by TLR4-NF-κB signaling through upregulation of the autophagy receptor, p62/SQSTM1. Thus, our results uncover a microglia-specific α-synuclein degradation pathway termed synucleinphagy that regulates α-synuclein homeostasis in the CNS. RESULTS Neuron-released α-synuclein is engulfed by microglia in vivo To understand microglia and α-synuclein interaction in vivo, we employed two mouse models, both of which express wild-type (WT) human α-synuclein (hα-Syn) in a neuron-specific manner. We first verified that mice injected with adeno-associated virus 9 (AAV9) carrying green fluorescent protein (GFP) under the synapsin promoter into the Substantia Nigra pars compacta (SNpc) expressed GFP strictly in neurons (Supplementary Fig. 1a, b). Mice injected with AAV9-hα-Syn in the SNpc showed loss of dopaminergic neurons on the ipsilateral side (Supplementary Fig. 1c), as reported29. In fact, dopamine transporter (DAT) and tyrosine hydroxylase (TH) protein levels were reduced compared with AAV9-GFP-injected mice (Supplementary Fig. 1d, e). Moreover, AAV9-hα-Syn, but not AAV9-GFP injection, caused microglial activation in the striatum as evidenced by the reduced length of processes and terminal branch points as well as increased cell number (Fig. 1a, b). [Figure: Neuron-released α-synuclein is engulfed by microglia in vivo.a, b, f, g Brain sections from AAV-GFP (n = 768 cells, six animals) and AAV-hα-Syn-injected mice (n = 986 cells, six animals) at 6 weeks post AAV injection (a, b) or from 10-month-old Non-Tg (n = 246 cells, three animals) and hα-Syn-Tg (n = 478cells, seven animals) mice (f, g) were stained for a marker of microglia, Iba-1, to visualize microglia morphology in the striatum. Reconstruction of microglia processes was generated by Filament-Tracer tool in Imaris software (a, e) and filament lengths (p < 0.0001) and the number of terminal points (p < 0.0001) were quantified (left panels in b and g). The number of microglia at the striatum was counted using ImageJ software (NIH, Bethesda, MD) (right panel in b (p = 6.59E-07) and g (p = 4.88E-05)). p-values were calculated by two-tailed Mann–Whitney U test (the left two panels) and unpaired two-tailed Student’s t test (the right panel). Scale bar, 10 µm. c CD45intermediate and CD11bhigh microglia were isolated from brains injected with AAV-hα-Syn (n = 3) and assayed for RT-qPCR using primers as indicated, compared with AAV-GFP (n = 3) at 4-weeks after AAV. p-values were calculated by unpaired two-tailed Student’s t test. d, h Pooled CD45intermediate and CD11bhigh microglia were prepared either from AAV-GFP (n = 3) and AAV-hα-Syn-injected mice (n = 3) (d) or Non-Tg (n = 4) and hα-Syn-Tg (n = 4) mice (h) brains at the indicated time points and lysed for W.B using α-synuclein antibodies (MJFR1 clone in d, 2F12 clone in h) and actin. e, i Brain sections from Cx3cr1CreER-IRES-Eyfp mice injected with AAV-hα-Syn were stained using anti-GFP/YFP antibody and human α-synuclein antibody at 6 weeks after AAV (e), and brain sections from 10-month-old Non-Tg and α-Syn-Tg mice were stained using Iba-1 antibody and human α-Synuclein antibody (i). 3D reconstruction of microglia and human α-synuclein was produced using Imaris software (Bitplane, right panel) as described in the “Methods" section. Scale bar, 10 µm. All values are reported as mean ± SEM. Data are representative of three independent experiments.] By RT-qPCR analysis of microglia state-specific gene expression30–32, we found upregulation of several disease-associated signature genes such as ApoE, Axl, and Lpl, inflammatory gene Tnf, and Tgfbr1 at 4-weeks post AAV injection (Fig. 1c; Supplementary Fig. 2). Importantly, we verified the presence of hα-Syn protein in isolated microglia via western blot with hα-Syn-specific antibody (Fig. 1d; Supplementary Fig. 3a). Using Cx3cr1CreER-IRES-Eyfp transgenic mice33, which express enhanced yellow fluorescent protein (EYFP) under the microglia-specific Cx3cr1 promoter, we detected hα-Syn in Cx3cr1-EYFP-positive microglia (Fig. 1e; Supplementary Fig. 3b). In transgenic mice overexpressing hα-Syn under the Thy-1 promoter (hα-Syn-Tg), we also found microglial activation in the striatum of 10-month-old mice (Fig. 1f, g). hα-Syn protein was clearly present in microglia through western blot analysis (Fig. 1h) and immunofluorescent staining in Iba-1-positive microglia at

Read the complete text